- Home
- CRDF vs OPFI Comparison
CRDF vs OPFI Comparison
Compare CRDF & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- OPFI
- Stock Information
- Founded
- CRDF 1999
- OPFI 2009
- Country
- CRDF United States
- OPFI United States
- Employees
- CRDF N/A
- OPFI N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- OPFI Finance: Consumer Services
- Sector
- CRDF Health Care
- OPFI Finance
- Exchange
- CRDF Nasdaq
- OPFI Nasdaq
- Market Cap
- CRDF 288.7M
- OPFI N/A
- IPO Year
- CRDF N/A
- OPFI N/A
- Fundamental
- Price
- CRDF $3.73
- OPFI $10.87
- Analyst Decision
- CRDF Strong Buy
- OPFI Buy
- Analyst Count
- CRDF 4
- OPFI 2
- Target Price
- CRDF $12.00
- OPFI $7.50
- AVG Volume (30 Days)
- CRDF 1.2M
- OPFI 1.5M
- Earning Date
- CRDF 05-01-2025
- OPFI 03-05-2025
- Dividend Yield
- CRDF N/A
- OPFI 1.12%
- EPS Growth
- CRDF N/A
- OPFI N/A
- EPS
- CRDF N/A
- OPFI 0.36
- Revenue
- CRDF $683,000.00
- OPFI $276,770,000.00
- Revenue This Year
- CRDF N/A
- OPFI N/A
- Revenue Next Year
- CRDF N/A
- OPFI $15.34
- P/E Ratio
- CRDF N/A
- OPFI $29.86
- Revenue Growth
- CRDF 39.96
- OPFI 22.23
- 52 Week Low
- CRDF $2.01
- OPFI $2.35
- 52 Week High
- CRDF $6.38
- OPFI $17.73
- Technical
- Relative Strength Index (RSI)
- CRDF 45.87
- OPFI 55.19
- Support Level
- CRDF $3.65
- OPFI $9.33
- Resistance Level
- CRDF $3.88
- OPFI $10.14
- Average True Range (ATR)
- CRDF 0.26
- OPFI 0.65
- MACD
- CRDF -0.02
- OPFI 0.24
- Stochastic Oscillator
- CRDF 30.00
- OPFI 90.50
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").